Histogen (HSTO) Stock Price, News & Analysis

Company Overview

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

Key Stats

• Today's Range: $0.21 to $0.21
• 50-Day Range: $0.21 to $0.30
• 52-Week Range: $0.05 to $0.55
• Volume: 166 shs
• Average Volume: 10,731 shs
• Market Capitalization: $897,120.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HSTO Stock Analysis - Frequently Asked Questions

How have HSTO shares performed this year?

Histogen's stock was trading at $0.3077 at the beginning of the year. Since then, HSTO shares have decreased by 31.8% and is now trading at $0.21.
View the best growth stocks for 2024 here.

How were Histogen's earnings last quarter?

Histogen Inc. (NASDAQ:HSTO) issued its earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share for the quarter, topping the consensus estimate of ($2.20) by $0.40. The company had revenue of $0.59 million for the quarter.

When did Histogen's stock split?

Histogen's stock reverse split on Friday, June 3rd 2022. The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Histogen?

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Histogen own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Palantir Technologies (PLTR), Tesla (TSLA), Bionano Genomics (BNGO), Applied Genetic Technologies (AGTC), HubSpot (HUBS), Meta Platforms (META) and TherapeuticsMD (TXMD).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 11/04/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:HSTO
• CUSIP: N/A
• CIK: 1383701
• Web: www.histogen.com
• Phone: (858) 526-3100
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $19,000.00
• Price / Sales: 47.22
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.13 per share
• Price / Book: 0.07

Miscellaneous

• Outstanding Shares: 4,272,000
• Free Float: 4,131,000
• Market Cap: $897,120.00
• Optionable: Not Optionable
• Beta: 1.19